Pharma Pfizer, in an attempt to bolster its oncology portfolio, is set to acquire Array Biopharma for USD 10.6 billion in the second half of 2019. The deal will give Pfizer access to Array’s cancer treatments which are showing promise in phase III trials and protect it against the looming patent…
Array Jeffrey Williams, Assistant Vice President of Cognizant Philippines, talks about the high rate of Filipino nurses being outsourced to the US and other countries, the recent acquisition of the Medicall by Cognizant, and what the future growth plans look like for the company’s next five years. Mr. Williams, you…
Array Margarita Paz, Managing Director of Total Transcript Solutions (TTSI) Philippines, talks about the reason behind switching to the medical transcription business, despite her nursing degree, how this has become a common occurrence in the Philippines, and why she feels TTSI has a very bright and successful future ahead. From…
Array Raul Manlapig, Principal Managing Director of Arup, Philippines, talks about the current rapid growth of the country’s economy, how the company’s sustained presence in many countries around the world provides for a good understanding of the local market and swift adaptability to market conditions and business trends, and why sustainability…
Array Maria Cristina G. Coronel (‘Beng’), President of Pointwest Technologies, and colleagues Rhea Latoga and Ma. Lillibeth Daffon (‘Beth’), discuss the current high growth rate within the healthcare sector, why being both an IT and BPO company, Pointwest Technologies has an edge over companies that focus on BPO alone, and how…
Array The managing partner, along with two other partners from ByrneWallace discuss the current legal framework in Ireland for small to mid-size companies operating in the pharmaceutical sector. Can you please introduce our readers to yourselves and the firm? Catherine Guy: I’m the current Managing Partner of ByrneWallace—the 7th largest law…
Array In Taiwan, biotech is finally booming, and more and more of the companies benefitting from this boom are listing on the Gre Tai Securities Market (GTSM), built with small to medium enterprises in mind, and tailored for companies that are part of emerging industries. But are these companies overvalued, and…
Array Deborah Brown, President of EMD Serono Canada, talks about Canada’s emerging market mentality, despite being a developed country, and how this lack of innovation and risk-taking could ultimately break Canada’s healthcare system if not addressed immediately. You have been responsible for a number of EMD Serono product launches in Canada;…
Array Steve Yang, Chief Executive Officer of Metiska Farma, talks about the changes he implemented to the comopany once he took over for his father in 2009 and what it means for the future of the company, both locally in Indonesia and on an international level. Mr. Yang, can you begin…
Array Endang W. Hoyaranda, President Director of Prodia Group, speaks about the ongoing challenges of clinical trials in Indonesia, especially in remote medical communities, and why changing the mindset from ‘guinea pig’ testing to medical advancement opportunities is key to changing the landscape of clinical trials in the country. Although Prodia…
Array António Leão, General Manager of Lilly, Portugal, talks about adapting to a challenging economic environment, as well as the importance of the company’s portfolio and pipeline, in Portugal today. Why did you decide to take on the position of general manager in early 2012, at a time when Portugal was…
Array Eduardo Pinto Leite, Director General of GSK Portugal, talks about the recent Portugal bailout, how its effects pushed GSK to some tough decision, and why he sees a brighter future for the company, and country, despite all the recent economic and market turmoil. You started running this affiliate in 2010,…
See our Cookie Privacy Policy Here